StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.22−0.16 (-11.59%)

Close on Nov 17, 2026Market cap $27.65MP/E –Yield –

BioHarvest Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$7.23M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.23M–
FY2024Dec 31, 2024-$6.68M–
FY2023Dec 31, 2023-$8.52M–

More BioHarvest Sciences figures

See a number that looks wrong?